JG
Jafarali Gulambhai Vaghmar
About Jafarali Gulambhai Vaghmar
Data last updated:
Jafarali Gulambhai Vaghmar is a Director at Sme Pharma Private Limited (since 2025). Earlier, Jafarali Gulambhai Vaghmar was a Designated Partner at Sme Pharma Llp (from 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Nov 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 14 Feb 2025 | 2025 | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jafarali Gulambhai Vaghmar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jafarali Rahimbhai Manasiya | 10378141 | Sme Pharma Private Limited | Director |
| Mahemudhasan Akbarali Kadiwala | 10948828 | Sme Pharma Private Limited | Director |
| Sanjay Prasad Sarjuprasad Kushwaha | 09285284 | Sme Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jafarali Gulambhai Vaghmar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jafarali Gulambhai Vaghmar
Jafarali Gulambhai Vaghmar currently holds 1 directorship: Sme Pharma Private Limited (Director, since 18 Nov 2025).
Jafarali Gulambhai Vaghmar was first appointed on 14 Feb 2025 as Designated Partner at Sme Pharma Llp.
Jafarali Gulambhai Vaghmar held 1 earlier board appointment: Sme Pharma Llp (Designated Partner, from 14 Feb 2025).
The current boards of Jafarali Gulambhai Vaghmar's companies include Jafarali Rahimbhai Manasiya (Sme Pharma Private Limited), Mahemudhasan Akbarali Kadiwala (Sme Pharma Private Limited), Sanjay Prasad Sarjuprasad Kushwaha (Sme Pharma Private Limited).